DORALESE

This brand name is authorized in UK.

Active ingredients

The drug DORALESE contains one active pharmaceutical ingredient (API):

1	Indoramin UNII DQ0Z3K8W92 - INDORAMIN HYDROCHLORIDE
	Indoramin is an alpha adrenoceptor blocking agent. It acts selectively and competitively on post-synaptic alpha-1 receptors, causing a decrease in peripheral resistance. It also produces relaxation of hyperplastic muscle in the prostate.
	Read more about Indoramin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DORALESE Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02CA02	Indoramin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	161598, 33550